Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 58 entries
Sorted by: Best Match Show Resources per page
Medium-to-high prevalence of screening-detected parkinsonism in the urban area of Tehran, Iran: data from a community-based door-to-door study.

Neuropsychiatric disease and treatment

Fereshtehnejad SM, Shafieesabet M, Rahmani A, Delbari A, Lökk J.
PMID: 25709455
Neuropsychiatr Dis Treat. 2015 Feb 05;11:321-32. doi: 10.2147/NDT.S77391. eCollection 2015.

INTRODUCTION: Parkinsonism occurs in all ethnic groups worldwide; however, there are wide variations in the prevalence rates reported from different countries, even for neighboring regions. The huge socioeconomic burden of parkinsonism necessitates the need for prevalence studies in each...

Cite
Fereshtehnejad SM, Shafieesabet M, Rahmani A, et al. Medium-to-high prevalence of screening-detected parkinsonism in the urban area of Tehran, Iran: data from a community-based door-to-door study. Neuropsychiatr Dis Treat. 2015;11:321-32doi: 10.2147/NDT.S77391.
Fereshtehnejad, S. M., Shafieesabet, M., Rahmani, A., Delbari, A., & Lökk, J. (2015). Medium-to-high prevalence of screening-detected parkinsonism in the urban area of Tehran, Iran: data from a community-based door-to-door study. Neuropsychiatric disease and treatment, 11321-32. https://doi.org/10.2147/NDT.S77391
Fereshtehnejad, Seyed-Mohammad, et al. "Medium-to-high prevalence of screening-detected parkinsonism in the urban area of Tehran, Iran: data from a community-based door-to-door study." Neuropsychiatric disease and treatment vol. 11 (2015): 321-32. doi: https://doi.org/10.2147/NDT.S77391
Fereshtehnejad SM, Shafieesabet M, Rahmani A, Delbari A, Lökk J. Medium-to-high prevalence of screening-detected parkinsonism in the urban area of Tehran, Iran: data from a community-based door-to-door study. Neuropsychiatr Dis Treat. 2015 Feb 05;11:321-32. doi: 10.2147/NDT.S77391. eCollection 2015. PMID: 25709455; PMCID: PMC4327401.
Copy Download .nbib Format: NLM
Parkinson's Disease Subtypes: Critical Appraisal and Recommendations.

Journal of Parkinson's disease

Mestre TA, Fereshtehnejad SM, Berg D, Bohnen NI, Dujardin K, Erro R, Espay AJ, Halliday G, van Hilten JJ, Hu MT, Jeon B, Klein C, Leentjens AFG, Marinus J, Mollenhauer B, Postuma R, Rajalingam R, Rodríguez-Violante M, Simuni T, Surmeier DJ, Weintraub D, McDermott MP, Lawton M, Marras C.
PMID: 33682731
J Parkinsons Dis. 2021;11(2):395-404. doi: 10.3233/JPD-202472.

BACKGROUND: In Parkinson's disease (PD), there is heterogeneity in the clinical presentation and underlying biology. Research on PD subtypes aims to understand this heterogeneity with potential contribution for the knowledge of disease pathophysiology, natural history and therapeutic development. There...

Cite
Mestre TA, Fereshtehnejad SM, Berg D, et al. Parkinson's Disease Subtypes: Critical Appraisal and Recommendations. J Parkinsons Dis. 2021;11(2):395-404doi: 10.3233/JPD-202472.
Mestre, T. A., Fereshtehnejad, S. M., Berg, D., Bohnen, N. I., Dujardin, K., Erro, R., Espay, A. J., Halliday, G., van Hilten, J. J., Hu, M. T., Jeon, B., Klein, C., Leentjens, A. F. G., Marinus, J., Mollenhauer, B., Postuma, R., Rajalingam, R., Rodríguez-Violante, M., Simuni, T., Surmeier, D. J., Weintraub, D., McDermott, M. P., Lawton, M., & Marras, C. (2021). Parkinson's Disease Subtypes: Critical Appraisal and Recommendations. Journal of Parkinson's disease, 11(2), 395-404. https://doi.org/10.3233/JPD-202472
Mestre, Tiago A, et al. "Parkinson's Disease Subtypes: Critical Appraisal and Recommendations." Journal of Parkinson's disease vol. 11,2 (2021): 395-404. doi: https://doi.org/10.3233/JPD-202472
Mestre TA, Fereshtehnejad SM, Berg D, Bohnen NI, Dujardin K, Erro R, Espay AJ, Halliday G, van Hilten JJ, Hu MT, Jeon B, Klein C, Leentjens AFG, Marinus J, Mollenhauer B, Postuma R, Rajalingam R, Rodríguez-Violante M, Simuni T, Surmeier DJ, Weintraub D, McDermott MP, Lawton M, Marras C. Parkinson's Disease Subtypes: Critical Appraisal and Recommendations. J Parkinsons Dis. 2021;11(2):395-404. doi: 10.3233/JPD-202472. PMID: 33682731; PMCID: PMC8150501.
Copy Download .nbib Format: NLM
X-ray radiation and the risk of multiple sclerosis: Do the site and dose of exposure matter?.

Medical journal of the Islamic Republic of Iran

Motamed MR, Fereshtehnejad SM, Abbasi M, Sanei M, Abbaslou M, Meysami S.
PMID: 25695003
Med J Islam Repub Iran. 2014 Dec 09;28:145. eCollection 2014.

BACKGROUND: The sporadic cases of radiation-activated multiple sclerosis (MS) has been previously described, with a few studies focused on the relationship between radiation and the risk of MS. The aim of our study was to evaluate the association between...

Cite
Motamed MR, Fereshtehnejad SM, Abbasi M, et al. X-ray radiation and the risk of multiple sclerosis: Do the site and dose of exposure matter?. Med J Islam Repub Iran. 2014;28:145
Motamed, M. R., Fereshtehnejad, S. M., Abbasi, M., Sanei, M., Abbaslou, M., & Meysami, S. (2014). X-ray radiation and the risk of multiple sclerosis: Do the site and dose of exposure matter?. Medical journal of the Islamic Republic of Iran, 28145.
Motamed, Mohammad Reza, et al. "X-ray radiation and the risk of multiple sclerosis: Do the site and dose of exposure matter?." Medical journal of the Islamic Republic of Iran vol. 28 (2014): 145.
Motamed MR, Fereshtehnejad SM, Abbasi M, Sanei M, Abbaslou M, Meysami S. X-ray radiation and the risk of multiple sclerosis: Do the site and dose of exposure matter?. Med J Islam Repub Iran. 2014 Dec 09;28:145. eCollection 2014. PMID: 25695003; PMCID: PMC4322346.
Copy Download .nbib Format: NLM
Extra-axial medulloblastoma in cerebello-pontine angle: A report of a rare case with literature review.

Medical journal of the Islamic Republic of Iran

Bahrami E, Bakhti S, Fereshtehnejad SM, Parvaresh M, Khani MR.
PMID: 25405123
Med J Islam Repub Iran. 2014 Jul 13;28:57. eCollection 2014.

Medulloblastoma is quite uncommon in the adult population and even rarer in extra-axial site in cerebello-pontine (CP) angle. In this report, a 23-year-old male patient with a two month history of deafness, nausea, vomiting and ataxia is presented. Clinical...

Cite
Bahrami E, Bakhti S, Fereshtehnejad SM, et al. Extra-axial medulloblastoma in cerebello-pontine angle: A report of a rare case with literature review. Med J Islam Repub Iran. 2014;28:57
Bahrami, E., Bakhti, S., Fereshtehnejad, S. M., Parvaresh, M., & Khani, M. R. (2014). Extra-axial medulloblastoma in cerebello-pontine angle: A report of a rare case with literature review. Medical journal of the Islamic Republic of Iran, 2857.
Bahrami, Eshagh, et al. "Extra-axial medulloblastoma in cerebello-pontine angle: A report of a rare case with literature review." Medical journal of the Islamic Republic of Iran vol. 28 (2014): 57.
Bahrami E, Bakhti S, Fereshtehnejad SM, Parvaresh M, Khani MR. Extra-axial medulloblastoma in cerebello-pontine angle: A report of a rare case with literature review. Med J Islam Repub Iran. 2014 Jul 13;28:57. eCollection 2014. PMID: 25405123; PMCID: PMC4219907.
Copy Download .nbib Format: NLM
Pathological Location of Cranial Nerves in Petroclival Lesions: How to Avoid Their Injury during Anterior Petrosal Approach.

Journal of neurological surgery. Part B, Skull base

Borghei-Razavi H, Tomio R, Fereshtehnejad SM, Shibao S, Schick U, Toda M, Yoshida K, Kawase T.
PMID: 28035290
J Neurol Surg B Skull Base. 2016 Feb;77(1):6-13. doi: 10.1055/s-0035-1555137. Epub 2015 Jun 19.

No abstract available.

Cite
Borghei-Razavi H, Tomio R, Fereshtehnejad SM, et al. Pathological Location of Cranial Nerves in Petroclival Lesions: How to Avoid Their Injury during Anterior Petrosal Approach. J Neurol Surg B Skull Base. 2015;77(1):6-13doi: 10.1055/s-0035-1555137.
Borghei-Razavi, H., Tomio, R., Fereshtehnejad, S. M., Shibao, S., Schick, U., Toda, M., Yoshida, K., & Kawase, T. (2016). Pathological Location of Cranial Nerves in Petroclival Lesions: How to Avoid Their Injury during Anterior Petrosal Approach. Journal of neurological surgery. Part B, Skull base, 77(1), 6-13. https://doi.org/10.1055/s-0035-1555137
Borghei-Razavi, Hamid, et al. "Pathological Location of Cranial Nerves in Petroclival Lesions: How to Avoid Their Injury during Anterior Petrosal Approach." Journal of neurological surgery. Part B, Skull base vol. 77,1 (2016): 6-13. doi: https://doi.org/10.1055/s-0035-1555137
Borghei-Razavi H, Tomio R, Fereshtehnejad SM, Shibao S, Schick U, Toda M, Yoshida K, Kawase T. Pathological Location of Cranial Nerves in Petroclival Lesions: How to Avoid Their Injury during Anterior Petrosal Approach. J Neurol Surg B Skull Base. 2016 Feb;77(1):6-13. doi: 10.1055/s-0035-1555137. Epub 2015 Jun 19. PMID: 28035290; PMCID: PMC5192549.
Copy Download .nbib Format: NLM
Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem).

Neuropsychiatric disease and treatment

Fereshtehnejad SM, Religa D, Westman E, Aarsland D, Lökk J, Eriksdotter M.
PMID: 23847419
Neuropsychiatr Dis Treat. 2013;9:927-35. doi: 10.2147/NDT.S45840. Epub 2013 Jun 28.

INTRODUCTION: Whether dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD) should be considered as one entity or two distinct conditions is a matter of controversy. The aim of this study was to compare the characteristics of...

Cite
Fereshtehnejad SM, Religa D, Westman E, et al. Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem). Neuropsychiatr Dis Treat. 2013;9:927-35doi: 10.2147/NDT.S45840.
Fereshtehnejad, S. M., Religa, D., Westman, E., Aarsland, D., Lökk, J., & Eriksdotter, M. (2013). Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem). Neuropsychiatric disease and treatment, 9927-35. https://doi.org/10.2147/NDT.S45840
Fereshtehnejad, Seyed-Mohammad, et al. "Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)." Neuropsychiatric disease and treatment vol. 9 (2013): 927-35. doi: https://doi.org/10.2147/NDT.S45840
Fereshtehnejad SM, Religa D, Westman E, Aarsland D, Lökk J, Eriksdotter M. Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem). Neuropsychiatr Dis Treat. 2013;9:927-35. doi: 10.2147/NDT.S45840. Epub 2013 Jun 28. PMID: 23847419; PMCID: PMC3700781.
Copy Download .nbib Format: NLM
Biological removal of phenol from saline wastewater using a moving bed biofilm reactor containing acclimated mixed consortia.

SpringerPlus

Nakhli SA, Ahmadizadeh K, Fereshtehnejad M, Rostami MH, Safari M, Borghei SM.
PMID: 24616843
Springerplus. 2014 Feb 26;3:112. doi: 10.1186/2193-1801-3-112. eCollection 2014.

In this study, the performance of an aerobic moving bed biofilm reactor (MBBR) was assessed for the removal of phenol as the sole substrate from saline wastewater. The effect of several parameters namely inlet phenol concentration (200-1200 mg/L), hydraulic...

Cite
Nakhli SA, Ahmadizadeh K, Fereshtehnejad M, et al. Biological removal of phenol from saline wastewater using a moving bed biofilm reactor containing acclimated mixed consortia. Springerplus. 2014;3:112doi: 10.1186/2193-1801-3-112.
Nakhli, S. A., Ahmadizadeh, K., Fereshtehnejad, M., Rostami, M. H., Safari, M., & Borghei, S. M. (2014). Biological removal of phenol from saline wastewater using a moving bed biofilm reactor containing acclimated mixed consortia. SpringerPlus, 3112. https://doi.org/10.1186/2193-1801-3-112
Nakhli, Seyyed Ali Akbar, et al. "Biological removal of phenol from saline wastewater using a moving bed biofilm reactor containing acclimated mixed consortia." SpringerPlus vol. 3 (2014): 112. doi: https://doi.org/10.1186/2193-1801-3-112
Nakhli SA, Ahmadizadeh K, Fereshtehnejad M, Rostami MH, Safari M, Borghei SM. Biological removal of phenol from saline wastewater using a moving bed biofilm reactor containing acclimated mixed consortia. Springerplus. 2014 Feb 26;3:112. doi: 10.1186/2193-1801-3-112. eCollection 2014. PMID: 24616843; PMCID: PMC3946108.
Copy Download .nbib Format: NLM
Orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism.

Parkinson's disease

Fereshtehnejad SM, Lökk J.
PMID: 24634790
Parkinsons Dis. 2014;2014:475854. doi: 10.1155/2014/475854. Epub 2014 Feb 02.

Orthostatic hypotension (OH) is one of the commonly occurring nonmotor symptoms in patients with idiopathic Parkinson's disease (IPD) and atypical parkinsonism (AP). We aimed to review current evidences on epidemiology, diagnosis, treatment, and prognosis of OH in patients with...

Cite
Fereshtehnejad SM, Lökk J. Orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. Parkinsons Dis. 2014;2014:475854doi: 10.1155/2014/475854.
Fereshtehnejad, S. M., & Lökk, J. (2014). Orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. Parkinson's disease, 2014475854. https://doi.org/10.1155/2014/475854
Fereshtehnejad, Seyed-Mohammad, and Lökk, Johan. "Orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism." Parkinson's disease vol. 2014 (2014): 475854. doi: https://doi.org/10.1155/2014/475854
Fereshtehnejad SM, Lökk J. Orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. Parkinsons Dis. 2014;2014:475854. doi: 10.1155/2014/475854. Epub 2014 Feb 02. PMID: 24634790; PMCID: PMC3929346.
Copy Download .nbib Format: NLM
Comparison of the Serum Electrolyte Levels among Patients Died and Survived in the Intensive Care Unit.

Tanaffos

Mousavi SA, Shahabi S, Mostafapour E, Purfakharan M, Fereshtehnejad SM, Amini J, Khojandi M, Raji H.
PMID: 25191436
Tanaffos. 2012;11(4):36-42.

BACKGROUND: This study aimed to evaluate the prevalence of serum sodium and potassium disorders and assess their effects on mortality rate in hospitalized patients in the ICU and also to identify prognosis and predictors of survival.MATERIALS AND METHODS: A...

Cite
Mousavi SA, Shahabi S, Mostafapour E, et al. Comparison of the Serum Electrolyte Levels among Patients Died and Survived in the Intensive Care Unit. Tanaffos. 2012;11(4):36-42
Mousavi, S. A., Shahabi, S., Mostafapour, E., Purfakharan, M., Fereshtehnejad, S. M., Amini, J., Khojandi, M., & Raji, H. (2012). Comparison of the Serum Electrolyte Levels among Patients Died and Survived in the Intensive Care Unit. Tanaffos, 11(4), 36-42.
Mousavi, Seyed-Ali Javad, et al. "Comparison of the Serum Electrolyte Levels among Patients Died and Survived in the Intensive Care Unit." Tanaffos vol. 11,4 (2012): 36-42.
Mousavi SA, Shahabi S, Mostafapour E, Purfakharan M, Fereshtehnejad SM, Amini J, Khojandi M, Raji H. Comparison of the Serum Electrolyte Levels among Patients Died and Survived in the Intensive Care Unit. Tanaffos. 2012;11(4):36-42. PMID: 25191436; PMCID: PMC4153215.
Copy Download .nbib Format: NLM
Comparison of the serum concentration of zinc in patients with bronchiectasis and control group.

Iranian Red Crescent medical journal

Javadmoosavi SA, Shahabi Shahmiri S, Mostafapour E, Purfakharan M, Zamanzadeh M, Fereshtehnejad SM, Raji H.
PMID: 24396578
Iran Red Crescent Med J. 2013 Jul;15(7):587-9. doi: 10.5812/ircmj.7735. Epub 2013 Jul 05.

BACKGROUND: Bronchiectasis is an abnormal and permanent dilatation of bronchi. Infection plays a major role in causing and perpetuating bronchiectasis, as reducing the microbial load and attendant mediators are cornerstone of therapy. Zinc, as an integral micronutrient is involved...

Cite
Javadmoosavi SA, Shahabi Shahmiri S, Mostafapour E, et al. Comparison of the serum concentration of zinc in patients with bronchiectasis and control group. Iran Red Crescent Med J. 2013;15(7):587-9doi: 10.5812/ircmj.7735.
Javadmoosavi, S. A., Shahabi Shahmiri, S., Mostafapour, E., Purfakharan, M., Zamanzadeh, M., Fereshtehnejad, S. M., & Raji, H. (2013). Comparison of the serum concentration of zinc in patients with bronchiectasis and control group. Iranian Red Crescent medical journal, 15(7), 587-9. https://doi.org/10.5812/ircmj.7735
Javadmoosavi, Seyed Ali, et al. "Comparison of the serum concentration of zinc in patients with bronchiectasis and control group." Iranian Red Crescent medical journal vol. 15,7 (2013): 587-9. doi: https://doi.org/10.5812/ircmj.7735
Javadmoosavi SA, Shahabi Shahmiri S, Mostafapour E, Purfakharan M, Zamanzadeh M, Fereshtehnejad SM, Raji H. Comparison of the serum concentration of zinc in patients with bronchiectasis and control group. Iran Red Crescent Med J. 2013 Jul;15(7):587-9. doi: 10.5812/ircmj.7735. Epub 2013 Jul 05. PMID: 24396578; PMCID: PMC3871746.
Copy Download .nbib Format: NLM
Sleep Disturbances in the Prodromal Stage of Parkinson Disease.

Current treatment options in neurology

Al-Qassabi A, Fereshtehnejad SM, Postuma RB.
PMID: 28466429
Curr Treat Options Neurol. 2017 Jun;19(6):22. doi: 10.1007/s11940-017-0458-1.

OPINION STATEMENT: Decades of research on neurodegenerative diseases such as Parkinson's disease (PD) have shifted our focus from clinical symptomatic stages to one step earlier, the prodromal stage. There is convincing evidence showing that sleep disorders such as excessive...

Cite
Al-Qassabi A, Fereshtehnejad SM, Postuma RB. Sleep Disturbances in the Prodromal Stage of Parkinson Disease. Curr Treat Options Neurol. 2017;19(6):22doi: 10.1007/s11940-017-0458-1.
Al-Qassabi, A., Fereshtehnejad, S. M., & Postuma, R. B. (2017). Sleep Disturbances in the Prodromal Stage of Parkinson Disease. Current treatment options in neurology, 19(6), 22. https://doi.org/10.1007/s11940-017-0458-1
Al-Qassabi, Ahmed, et al. "Sleep Disturbances in the Prodromal Stage of Parkinson Disease." Current treatment options in neurology vol. 19,6 (2017): 22. doi: https://doi.org/10.1007/s11940-017-0458-1
Al-Qassabi A, Fereshtehnejad SM, Postuma RB. Sleep Disturbances in the Prodromal Stage of Parkinson Disease. Curr Treat Options Neurol. 2017 Jun;19(6):22. doi: 10.1007/s11940-017-0458-1. PMID: 28466429.
Copy Download .nbib Format: NLM
Erratum to: Cardiovascular medication burden in dementia disorders: a nationwide study of 19, 743 dementia patients in the Swedish Dementia Registry.

Alzheimer's research & therapy

Cermakova P, Fereshtehnejad SM, Johnell K, Winblad B, Eriksdotter M, Religa D.
PMID: 25476876
Alzheimers Res Ther. 2014 Sep 20;6(5):63. doi: 10.1186/s13195-014-0063-4. eCollection 2014.

No abstract.[This corrects the article on p. 34 in vol. 6, PMID: 25024749.].

Cite
Cermakova P, Fereshtehnejad SM, Johnell K, et al. Erratum to: Cardiovascular medication burden in dementia disorders: a nationwide study of 19, 743 dementia patients in the Swedish Dementia Registry. Alzheimers Res Ther. 2014;6(5):63doi: 10.1186/s13195-014-0063-4.
Cermakova, P., Fereshtehnejad, S. M., Johnell, K., Winblad, B., Eriksdotter, M., & Religa, D. (2014). Erratum to: Cardiovascular medication burden in dementia disorders: a nationwide study of 19, 743 dementia patients in the Swedish Dementia Registry. Alzheimer's research & therapy, 6(5), 63. https://doi.org/10.1186/s13195-014-0063-4
Cermakova, Pavla, et al. "Erratum to: Cardiovascular medication burden in dementia disorders: a nationwide study of 19, 743 dementia patients in the Swedish Dementia Registry." Alzheimer's research & therapy vol. 6,5 (2014): 63. doi: https://doi.org/10.1186/s13195-014-0063-4
Cermakova P, Fereshtehnejad SM, Johnell K, Winblad B, Eriksdotter M, Religa D. Erratum to: Cardiovascular medication burden in dementia disorders: a nationwide study of 19, 743 dementia patients in the Swedish Dementia Registry. Alzheimers Res Ther. 2014 Sep 20;6(5):63. doi: 10.1186/s13195-014-0063-4. eCollection 2014. PMID: 25476876; PMCID: PMC4255535.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 58 entries